21.51MMarket Cap-847P/E (TTM)
16.5500High16.2900Low8.49KVolume16.5500Open16.5500Pre Close140.18KTurnover1.05%Turnover RatioLossP/E (Static)1.32MShares26.800052wk High1.15P/B13.16MFloat Cap6.200052wk Low--Dividend TTM808.13KShs Float780.0000Historical High--Div YieldTTM1.57%Amplitude6.2000Historical Low16.5090Avg Price1Lot Size
Pieris Pharmaceuticals Stock Forum
3 MINUTES AGO, 7:30 AM EDT
VIA GLOBENEWSWIRE
FDA Orphan Products Grants are based on scientific and technical merit as determined by rare disease and regulatory experts
Ongoing Phase 3 trial evaluating QTORIN™ 3.9% rapamycin...
PRNewswire 24-Jul-2024 2:55 PM
This firm never misses a merger! Dont know if they do good work on not but Damn! Its every one! Hehehe
$Pieris Pharmaceuticals (PIRS.US)$
No comment yet